[HTML][HTML] Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study

HM Dabbous, S Abd-Elsalam, MH El-Sayed… - Archives of …, 2021 - Springer
… This study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was
a … Therefore, the aim of the study was to evaluate the efficacy of favipiravir in treatment

[HTML][HTML] Treatment with zinc is associated with reduced in-hospital mortality among COVID-19 patients: a multi-center cohort study

JO Rahimian, S Yaghi, M Liu, A Lewis… - Research …, 2020 - ncbi.nlm.nih.gov
… A number of randomized trials of zinc among COVID-19 patients are currently underway and
should provide more definitive data. Second, we did not measure serum zinc levels prior to …

[HTML][HTML] A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19

MA Puskarich, NW Cummins, NE Ingraham… - …, 2021 - thelancet.com
randomized placebo-controlled clinical trial of symptomatic outpatients with COVID-19 not
already treated … statement: updated guidelines for reporting parallel group randomized trials. …

[HTML][HTML] Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: a randomized multi-center clinical trial

MS Niaee, P Namdar, A Allami, L Zolghadr… - Asian Pacific Journal …, 2021 - journals.lww.com
… Several clinical trial studies have reported the effect of ivermectin on the treatment of
COVID-19 patients[ 19 20 ]. The survey of studies on COVID-19 in recent months and ongoing …

[HTML][HTML] Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID19: a multicenter, open‐label, randomized controlled trial

US Perepu, I Chambers, A Wahab, P Ten Eyck… - Journal of Thrombosis …, 2021 - Elsevier
… a multicenter, open‐label, randomized controlled trialCOVID19 and admitted to an
intensive care unit (ICU) and/or had laboratory evidence of coagulopathy. Patients were randomly

[HTML][HTML] A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine …

S Takayama, T Namiki, T Ito, R Arita, H Nakae… - Trials, 2020 - Springer
… Kampo medicine and conventional treatment will significantly … of treatment as compared
with conventional treatment alone. … studies reporting the efficacy of Kampo medicine for COVID-…

[HTML][HTML] Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study

A Ip, J Ahn, Y Zhou, AH Goy, E Hansen… - BMC infectious …, 2021 - Springer
… in a prospective randomized trial. We aimed to explore the role of hydroxychloroquine … WI)
[17,18,19,20]. In this multi-center observational cohort study we report progression from mildly …

[HTML][HTML] … -dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study—VitCov Trial

F Jaun, M Boesing, G Lüthi-Corridori, K Abig… - Trials, 2022 - Springer
… The study aim is to test the hypothesis that patients with vitamin D deficiency … COVID-19
treated under standardized conditions in hospital will recover faster when additionally treated

Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: a randomized multi-center clinical trial.

M Shakhsi Niaee, P Namdar, A Allami… - … Pacific Journal Of …, 2021 - search.ebscohost.com
… Several clinical trial studies have reported the effect of ivermectin on the treatment of COVID-19
patients[19,20]… A randomized trial of hydroxychloroquine as postexposure prophylaxis for …

Outpatient treatment of COVID-19 and the development of long COVID Over 10 Months: A multi-center, quadruple-blind, parallel group randomized phase 3 trial

C Bramante, JB Buse, D Liebovitz, J Nicklas… - 2023 - papers.ssrn.com
… Long COVID diagnosis from a medical provider was a pre-specified secondary outcome …
days after randomization and confirmed in medical records. Findings: Of 1323 randomized trial